| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M311300200 |
| P698 | PubMed publication ID | 14752113 |
| P2093 | author name string | Per Westermark | |
| Ronald Wetzel | |||
| Brian O'Nuallain | |||
| Angela D Williams | |||
| P2860 | cites work | Solubilization and disaggregation of polyglutamine peptides | Q28361593 |
| A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR | Q28387681 | ||
| Abeta amyloid fibrils possess a core structure highly resistant to hydrogen exchange | Q28394786 | ||
| Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation | Q28610069 | ||
| Use of gene knockouts in cultured cells to study apoptosis | Q30668930 | ||
| Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1-42 mutants of familial Alzheimer's disease at positions 21-23. | Q31072457 | ||
| Fourteen and counting: unraveling trinucleotide repeat diseases | Q33892634 | ||
| Amyloid fibrils from muscle myoglobin | Q33937323 | ||
| Specificity in intracellular protein aggregation and inclusion body formation | Q33949081 | ||
| ??? | Q22251293 | ||
| Conformational Abs recognizing a generic amyloid fibril epitope | Q34009881 | ||
| Transmissibility of systemic amyloidosis by a prion-like mechanism | Q34068073 | ||
| The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation | Q34088689 | ||
| Rationalization of the effects of mutations on peptide and protein aggregation rates. | Q34222395 | ||
| Missense mutation of amylin gene (S20G) in Japanese NIDDM patients | Q34393899 | ||
| Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease | Q34729047 | ||
| Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers | Q35750568 | ||
| S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin | Q35829725 | ||
| Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence | Q36831406 | ||
| The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation | Q39665703 | ||
| Normal and abnormal biology of the beta-amyloid precursor protein | Q40766055 | ||
| The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus | Q40992063 | ||
| The structure of amyloid fibrils by electron microscopy and X-ray diffraction | Q41617137 | ||
| A microtiter plate assay for polyglutamine aggregate extension | Q43697872 | ||
| Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide | Q43854800 | ||
| Amyloid-like features of polyglutamine aggregates and their assembly kinetics | Q44014104 | ||
| Aggregation and neurotoxicity of mutant amyloid beta (A beta) peptides with proline replacement: importance of turn formation at positions 22 and 23. | Q44084637 | ||
| Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis | Q44700741 | ||
| Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity | Q45303479 | ||
| Structural and dynamic features of Alzheimer's Abeta peptide in amyloid fibrils studied by site-directed spin labeling. | Q45941938 | ||
| Conformational diversity in a yeast prion dictates its seeding specificity | Q46425975 | ||
| Generation of prion transmission barriers by mutational control of amyloid conformations | Q46432116 | ||
| Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. | Q46492867 | ||
| Prion domain initiation of amyloid formation in vitro from native Ure2p | Q46625178 | ||
| Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E. | Q46722154 | ||
| Abeta protofibrils possess a stable core structure resistant to hydrogen exchange | Q47361751 | ||
| Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides | Q48406520 | ||
| A beta deposition inhibitor screen using synthetic amyloid. | Q48790396 | ||
| In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics. | Q49161050 | ||
| Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). | Q50864761 | ||
| Insulin and Alzheimer's disease: an amyloid connection. | Q52007101 | ||
| Analysis of protein aggregation kinetics. | Q52143609 | ||
| Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro. | Q53231526 | ||
| Diabetes mellitus and the risk of dementia: The Rotterdam Study. | Q53231897 | ||
| Effects of sequential proline substitutions on amyloid formation by human amylin20-29. | Q54128400 | ||
| Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB | Q54131245 | ||
| Thioflavine T interaction with amyloid β-sheet structures | Q58258322 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 17490-17499 | |
| P577 | publication date | 2004-01-29 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Seeding specificity in amyloid growth induced by heterologous fibrils | |
| P478 | volume | 279 |
| Q52919726 | A Hot-Segment-Based Approach for the Design of Cross-Amyloid Interaction Surface Mimics as Inhibitors of Amyloid Self-Assembly. |
| Q34381799 | A distinct subfraction of Aβ is responsible for the high-affinity Pittsburgh compound B-binding site in Alzheimer's disease brain |
| Q41886432 | A kinetic aggregation assay allowing selective and sensitive amyloid-β quantification in cells and tissues |
| Q30827953 | A scFv antibody targeting common oligomeric epitope has potential for treating several amyloidoses |
| Q42546560 | Abeta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated |
| Q42018798 | Age-Dependent Protein Aggregation Initiates Amyloid-β Aggregation. |
| Q52803242 | Aggregating sequences that occur in many proteins constitute weak spots of bacterial proteostasis. |
| Q41513084 | Aggregation behavior of chemically synthesized, full-length huntingtin exon1. |
| Q41979763 | Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau |
| Q37671455 | Alzheimer's disease and the amyloid-beta peptide |
| Q96686037 | Amylin and beta amyloid proteins interact to form amorphous heterocomplexes with enhanced toxicity in neuronal cells |
| Q34352928 | Amylin deposition in the brain: A second amyloid in Alzheimer disease? |
| Q36483911 | Amylin-Aβ oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer's disease |
| Q46703068 | Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases |
| Q35586308 | Amyloid polymorphism: structural basis and neurobiological relevance |
| Q37016493 | Amyloid-a state in many guises: survival of the fittest fibril fold |
| Q36788949 | Amyloid-beta aggregation |
| Q45140488 | Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology. |
| Q48183597 | Amyloidosis in transgenic mice expressing murine amyloidogenic apolipoprotein A-II (Apoa2c). |
| Q38748337 | An Account of Amyloid Oligomers: Facts and Figures Obtained from Experiments and Simulations |
| Q79258635 | Analysis of amyloid fibril structure by scanning cysteine mutagenesis |
| Q34191817 | Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols |
| Q26824195 | Assessing the causes and consequences of co-polymerization in amyloid formation |
| Q89603623 | Association of plasma β-amyloid 40 and 42 concentration with type 2 diabetes among Chinese adults |
| Q36774319 | Bacterial curli protein promotes the conversion of PAP248-286 into the amyloid SEVI: cross-seeding of dissimilar amyloid sequences |
| Q29994589 | Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential |
| Q40785358 | C-Terminal Threonine Reduces Aβ43 Amyloidogenicity Compared with Aβ42. |
| Q45300857 | CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity. |
| Q33988231 | CDK5 is essential for soluble amyloid β-induced degradation of GKAP and remodeling of the synaptic actin cytoskeleton |
| Q58696552 | Characterisation of the Structure and Oligomerisation of Islet Amyloid Polypeptides (IAPP): A Review of Molecular Dynamics Simulation Studies |
| Q38901646 | Chiral recognition in amyloid fiber growth |
| Q46608412 | Cloning and Aggregation Characterization of Rubber Elongation Factor and Small Rubber Particle Protein from Ficus carica. |
| Q47251040 | Common fibrillar spines of amyloid-β and human Islet Amyloid Polypeptide revealed by Micro Electron Diffraction and inhibitors developed using structure-based design. |
| Q35612061 | Computational re-engineering of Amylin sequence with reduced amyloidogenic potential |
| Q30481423 | Conformational switching within individual amyloid fibrils. |
| Q36476796 | Contribution of the intrinsic disulfide to the assembly mechanism of islet amyloid |
| Q37585420 | Cross currents in protein misfolding disorders: interactions and therapy |
| Q45332712 | Cross-amyloid interaction of Aβ and IAPP at lipid membranes |
| Q38871578 | Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis |
| Q42046445 | Cross-seeding and cross-competition in mouse apolipoprotein A-II amyloid fibrils and protein A amyloid fibrils |
| Q44369500 | Cross-seeding between Aβ40 and Aβ42 in Alzheimer's disease |
| Q45293494 | Cross-seeding fibrillation of Q/N-rich proteins offers new pathomechanism of polyglutamine diseases |
| Q27021846 | Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases |
| Q37398112 | Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease |
| Q96431672 | Cryo-EM structure and inhibitor design of human IAPP (amylin) fibrils |
| Q96431669 | Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-β fibrils |
| Q34015348 | Curli provide the template for understanding controlled amyloid propagation |
| Q38831388 | Current and future treatment of amyloid diseases |
| Q89963670 | Cynomolgus Monkeys With Spontaneous Type-2-Diabetes-Mellitus-Like Pathology Develop Alpha-Synuclein Alterations Reminiscent of Prodromal Parkinson's Disease and Related Diseases |
| Q41906643 | D-polyglutamine amyloid recruits L-polyglutamine monomers and kills cells. |
| Q48933239 | Differential Regulation of N-Methyl-D-Aspartate Receptor Subunits is an Early Event in the Actions of Soluble Amyloid-β(1-40) Oligomers on Hippocampal Neurons. |
| Q79258620 | Direct observation of amyloid growth monitored by total internal reflection fluorescence microscopy |
| Q28575781 | Disassembly of shank and homer synaptic clusters is driven by soluble beta-amyloid(1-40) through divergent NMDAR-dependent signalling pathways |
| Q44269390 | Dissecting the role of single regions of an IAPP mimic and IAPP in inhibition of Aβ40 amyloid formation and cytotoxicity. |
| Q38305183 | Distinguishing closely related amyloid precursors using an RNA aptamer |
| Q33718596 | Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer's disease. |
| Q36894417 | Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes |
| Q41845860 | Eighty years of research on islet amyloidosis in Uppsala |
| Q64937259 | Enhancing face validity of mouse models of Alzheimer's disease with natural genetic variation. |
| Q100958921 | Enlightening amyloid fibrils linked to type 2 diabetes and cross-interactions with Aβ |
| Q89893387 | Entropic Bristles Tune the Seeding Efficiency of Prion-Nucleating Fragments |
| Q53513948 | Experimental and Computational Protocols for Studies of Cross-Seeding Amyloid Assemblies. |
| Q37171207 | Experimental manipulation of the microbial functional amyloid called curli. |
| Q37096279 | Exploring the basis of [PIN(+)] variant differences in [PSI(+)] induction |
| Q88490460 | FaptaSyme: A Strategy for Converting a Monomer/Oligomer-Nonselective Aptameric Sensor into an Oligomer-Selective One |
| Q41607092 | Fatty Acid Concentration and Phase Transitions Modulate Aβ Aggregation Pathways. |
| Q38932803 | Fiber-dependent and -independent toxicity of islet amyloid polypeptide |
| Q99418939 | Fibril structures of diabetes-related amylin variants reveal a basis for surface-templated assembly |
| Q33479158 | Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal model |
| Q45016854 | Full length amylin oligomer aggregation: insights from molecular dynamics simulations and implications for design of aggregation inhibitors. |
| Q35280161 | General amyloid inhibitors? A critical examination of the inhibition of IAPP amyloid formation by inositol stereoisomers |
| Q47121733 | Gold Nanoparticles as a Probe for Amyloid-β Oligomer and Amyloid Formation |
| Q35539781 | Heterologous aggregates promote de novo prion appearance via more than one mechanism. |
| Q90049855 | High-Fat Diet Increases Amylin Accumulation in the Hippocampus and Accelerates Brain Aging in hIAPP Transgenic Mice |
| Q51793976 | Highly promiscuous nature of prion polymerization. |
| Q45052920 | Identifying structural features of fibrillar islet amyloid polypeptide using site-directed spin labeling |
| Q37334382 | In silico cross seeding of Aβ and amylin fibril-like oligomers. |
| Q33941017 | In-cell aggregation of a polyglutamine-containing chimera is a multistep process initiated by the flanking sequence |
| Q80486794 | Inactivation of amyloid-enhancing factor (AEF): study on experimental murine AA amyloidosis |
| Q36479780 | Influence of temperature on formation of perfect tau fragment fibrils using PRIME20/DMD simulations |
| Q42330245 | Inhibition of peptide aggregation by means of enzymatic phosphorylation |
| Q36224635 | Insights into the consequences of co-polymerisation in the early stages of IAPP and Aβ peptide assembly from mass spectrometry |
| Q38829576 | Insulin amyloid at injection sites of patients with diabetes |
| Q41367406 | Interfacial interaction and lateral association of cross-seeding assemblies between hIAPP and rIAPP oligomers. |
| Q90356091 | Is the p3 Peptide (Aβ17-40, Aβ17-42) Relevant to the Pathology of Alzheimer's Disease?1 |
| Q47834508 | Islet Amyloid Polypeptide Promotes Amyloid-beta Aggregation by Binding-induced Helix-unfolding of the Amyloidogenic Core |
| Q91710089 | Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease |
| Q33732983 | Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts |
| Q50904206 | Key aromatic/hydrophobic amino acids controlling a cross-amyloid peptide interaction versus amyloid self-assembly. |
| Q39731518 | Kinetic profile of amyloid formation in the presence of an aromatic inhibitor by nuclear magnetic resonance |
| Q36088674 | Kinetically competing huntingtin aggregation pathways control amyloid polymorphism and properties |
| Q79258612 | Kinetics and thermodynamics of amyloid assembly using a high-performance liquid chromatography-based sedimentation assay |
| Q35699410 | Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains. |
| Q37915629 | Localized amyloids important in diseases outside the brain--lessons from the islets of Langerhans and the thoracic aorta |
| Q47636858 | Lysines in the RNA Polymerase II C-Terminal Domain Contribute to TAF15 Fibril Recruitment. |
| Q58722862 | Magnetic Nanoparticles Applications for Amyloidosis Study and Detection: A Review |
| Q36579443 | Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane |
| Q38056340 | Microbial manipulation of the amyloid fold |
| Q90212307 | Molecular Recognition between Aβ-Specific Single-Domain Antibody and Aβ Misfolded Aggregates |
| Q50079166 | Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases. |
| Q24633202 | Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases |
| Q39043775 | Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding |
| Q46631991 | Multiple ligand binding sites on A beta(1-40) fibrils |
| Q35139765 | Mutational analysis of preamyloid intermediates: the role of his-tyr interactions in islet amyloid formation |
| Q26751000 | Neuroendocrine hormone amylin in diabetes |
| Q38965068 | Neuroprotective peptide-macrocycle conjugates reveal complex structure-activity relationships in their interactions with amyloid β. |
| Q33883804 | Non-esterified fatty acids generate distinct low-molecular weight amyloid-β (Aβ42) oligomers along pathway different from fibril formation |
| Q34549794 | Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission |
| Q36175904 | Nonnative protein polymers: structure, morphology, and relation to nucleation and growth |
| Q35080634 | Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins |
| Q34838288 | Observations in APP bitransgenic mice suggest that diffuse and compact plaques form via independent processes in Alzheimer's disease |
| Q27022467 | On the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP Peptides |
| Q33958095 | Orthogonal cross-seeding: an approach to explore protein aggregates in living cells |
| Q36925198 | Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. |
| Q90142248 | Peptide-Based Molecular Strategies To Interfere with Protein Misfolding, Aggregation, and Cell Degeneration |
| Q28388530 | Phage display and peptide mapping of an immunoglobulin light chain fibril-related conformational epitope |
| Q37981477 | Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence |
| Q43100835 | Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism |
| Q35694039 | Polyglutamine expansion alters the dynamics and molecular architecture of aggregates in dentatorubropallidoluysian atrophy |
| Q51805155 | Polymorphic cross-seeding amyloid assemblies of amyloid-β and human islet amyloid polypeptide. |
| Q38960046 | Potential mechanisms and implications for the formation of tau oligomeric strains |
| Q48169675 | Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research |
| Q37080688 | Prion-prion interactions |
| Q57835686 | Probing amyloid fibril formation of the NFGAIL peptide by computer simulations |
| Q36318763 | Promiscuous cross-seeding between bacterial amyloids promotes interspecies biofilms |
| Q58800414 | Protein Co-Aggregation Related to Amyloids: Methods of Investigation, Diversity, and Classification |
| Q36085672 | Protein drug stability: a formulation challenge |
| Q91705222 | Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases |
| Q55080630 | Q-Rich Yeast Prion [PSI+] Accelerates Aggregation of Transthyretin, a Non-Q-Rich Human Protein. |
| Q46552313 | Replica exchange molecular dynamics simulation of cross-fibrillation of IAPP and PrP106-126. |
| Q39312627 | Resolution enhancement of suspended microchannel resonators for weighing of biomolecular complexes in solution |
| Q96171968 | Reverse engineering synthetic antiviral amyloids |
| Q37292040 | Review. Reflections on amyloidosis in Papua New Guinea |
| Q42570693 | Role of aromatic interactions in amyloid formation by islet amyloid polypeptide |
| Q39257498 | S100A6 amyloid fibril formation is calcium-modulated and enhances superoxide dismutase-1 (SOD1) aggregation |
| Q40307309 | Sampling the self-assembly pathways of KFFE hexamers |
| Q46786479 | Scanning cysteine mutagenesis analysis of Abeta-(1-40) amyloid fibrils |
| Q55713289 | Seed-Induced Heterogeneous Cross-Seeding Self-Assembly of Human and Rat Islet Polypeptides. |
| Q37159393 | Self-assembly of giant peptide nanobelts |
| Q34114138 | Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20 |
| Q48226802 | Sequence-Specific Protein Aggregation Generates Defined Protein Knockdowns in Plants |
| Q34671631 | Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid deposits |
| Q58277923 | Signs of cross-seeding: aortic medin amyloid as a trigger for protein AA deposition |
| Q36911406 | Small molecule inhibitors of Abeta assembly |
| Q46828851 | Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. |
| Q42078881 | Sonication of proteins causes formation of aggregates that resemble amyloid |
| Q30852039 | Structural properties of Abeta protofibrils stabilized by a small molecule. |
| Q90189862 | Structure and Aggregation Mechanisms in Amyloids |
| Q41907342 | Suppression of amyloid fibrils using the GroEL apical domain |
| Q46249812 | Surfactant-induced conformational transition of amyloid beta-peptide |
| Q37364765 | Switching in amyloid structure within individual fibrils: implication for strain adaptation, species barrier and strain classification |
| Q38844934 | ThT 101: a primer on the use of thioflavin T to investigate amyloid formation |
| Q59808453 | The Early Events That Initiate β-Amyloid Aggregation in Alzheimer's Disease |
| Q57279408 | The Role of Functional Amyloids in Bacterial Virulence |
| Q43822791 | The air-water interface determines the outcome of seeding during amyloidogenesis |
| Q28574836 | The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis |
| Q35927987 | The curli nucleator protein, CsgB, contains an amyloidogenic domain that directs CsgA polymerization |
| Q33822270 | The effect of Aβ on IAPP aggregation in the presence of an isolated β-cell membrane |
| Q34657827 | The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme: a biological perspective |
| Q39951771 | The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity |
| Q47265139 | The role of microbial amyloid in neurodegeneration. |
| Q38548820 | The route to protein aggregate superstructures: Particulates and amyloid-like spherulites. |
| Q39706243 | The sulfated triphenyl methane derivative acid fuchsin is a potent inhibitor of amyloid formation by human islet amyloid polypeptide and protects against the toxic effects of amyloid formation |
| Q92564159 | The triphenylmethane dye brilliant blue G is only moderately effective at inhibiting amyloid formation by human amylin or at disaggregating amylin amyloid fibrils, but interferes with amyloid assays; Implications for inhibitor design |
| Q38088318 | Therapeutic strategies against protein misfolding in neurodegenerative diseases |
| Q36793466 | Thinking laterally about neurodegenerative proteinopathies |
| Q37083241 | Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics. |
| Q51251681 | Toxicity of serum albumin on microglia upon seeding effect of amyloid peptide. |
| Q38784441 | Transmissible amyloid |
| Q42080116 | Transmissible proteins: expanding the prion heresy |
| Q42944341 | Transthyretin and amyloid in the islets of Langerhans in type-2 diabetes |
| Q47597491 | Two different types of amyloid deposits--apolipoprotein A-IV and transthyretin--in a patient with systemic amyloidosis |
| Q41774231 | Understanding co-polymerization in amyloid formation by direct observation of mixed oligomers |
| Q34193337 | Vascular and metabolic dysfunction in Alzheimer's disease: a review |
| Q36871202 | What amyloid ligands can tell us about molecular polymorphism and disease |
| Q42363775 | Wild type huntingtin toxicity in yeast: Implications for the role of amyloid cross-seeding in polyQ diseases. |
| Q50523933 | Yeast prion protein New1 can break Sup35 amyloid fibrils into fragments in an ATP-dependent manner. |
| Q34098314 | polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction |
| Q41117781 | β-Hairpin of Islet Amyloid Polypeptide Bound to an Aggregation Inhibitor |
| Q30155204 | β-sheet propensity controls the kinetic pathways and morphologies of seeded peptide aggregation |
Search more.